Does chronic hyperglycemia promote cerebral small-vessel injury?

Chronic hyperglycemia is a biologically credible contributor to cerebral small-vessel injury through endothelial dysfunction. The strongest evidence concerns glucose-driven oxidative stress; the full causal pathway to MRI-defined brain injury is supported mechanistically and clinically, but not definitively established as longitudinal mediation in humans.

Endothelial and nitric-oxide effects

• Excess glucose increases endothelial reactive oxygen species through NADPH oxidase activation, mitochondrial dysfunction, advanced glycation end-product formation, protein-kinase-C signaling, and polyol/hexosamine pathways.
• These oxidative and metabolic disturbances promote endothelial inflammatory signaling.
• Reactive oxygen species also reduce nitric-oxide (NO) bioavailability by directly inactivating NO, depleting tetrahydrobiopterin, and uncoupling endothelial NO synthase. This can create a feed-forward state favoring further superoxide generation.
• In people with type 1 and type 2 diabetes, impaired endothelium-dependent relaxation and reduced NO bioactivity are consistently observed, supporting clinically relevant endothelial dysfunction.

Relevance to cerebral small vessels

• Reduced NO impairs endothelium-dependent vasodilation and can promote vasoconstriction, inflammation, thrombosis, and vascular permeability. Together with inflammatory endothelial dysfunction, these processes can damage the cerebral endothelium and blood–brain barrier, contributing to small-vessel disease.
• In community cohorts, higher HbA1c—particularly ≥7%—is generally associated with greater white-matter-hyperintensity burden. Older adults with type 2 diabetes also have more lacunes, and diabetes duration has been associated with lacunes in at least one cohort. Age and coexisting vascular risks substantially confound these associations.

Bottom line

• The claim is plausible and substantially supported: chronic hyperglycemia promotes endothelial oxidative stress, inflammation, and reduced NO availability, with credible routes to cerebral small-vessel injury. The oxidative-stress link is particularly well established; direct proof that these endothelial abnormalities individually mediate progressive MRI-defined brain injury in humans remains less definitive.